Consider participating in a clinical research study to evaluate the effectiveness and safety of an oral study drug that may help slow the progression of mild to moderate Alzheimer’s disease.
To participate, you must be 55 to 85 years old with symptoms of mental or functional decline dating back at least a year. Your partner or caregiver must be willing to bring you to study visits. Other eligibility criteria apply.
Study-related drugs and care will be provided at no cost.
For more information about the potential benefits and risks of the study, please contact Natalie Stone, MS, CCRC:
research trials at HMG
Please contact us with your questions or comments. We look forward to hearing from you.